Can a CT Scan Detect Fibroids vs. Ultrasound or MRI? What Each Imaging Test Shows

Yes, a CT scan can detect uterine fibroids, but it is not the best test for them. CT reliably shows large fibroids that change the shape of the uterus, yet it misses small ones and cannot map location precisely enough to guide treatment. Ultrasound is the first-line test, and MRI is the most accurate. CT usually finds fibroids incidentally, while looking for something else.

The choice among these three tests comes down to what the fibroid looks like on each modality, and to what question you are asking. A woman with heavy bleeding and a suspected fibroid needs a different exam than a patient in the emergency department with abdominal pain. This explainer walks through the physics of each test, the detection thresholds published in the literature, the fibroid mimics that fool radiologists, and the practical steps that follow a finding.

How each modality forms a fibroid image

A fibroid is a benign tumor of smooth muscle and fibrous connective tissue. It begins as a small whorl inside the myometrium, the muscular wall of the uterus. As it grows, it may stay within the wall (intramural), bulge into the cavity (submucosal), or push outward under the serosa (subserosal). Each imaging test detects the lesion by a different physical property, which explains why their accuracy differs.

Ultrasound sends high-frequency sound waves into the pelvis and records the echoes. A fibroid reflects sound differently than normal muscle because its dense, whorled collagen scatters the beam. On a transvaginal scan, the probe sits a few centimeters from the uterus, so the transducer can use frequencies of roughly 5 to 9 megahertz and resolve structures a few millimeters across. That proximity is why ultrasound sees small fibroids well. A transabdominal scan uses lower frequencies and a longer path through the abdominal wall, so it resolves less detail.

CT measures how tissue attenuates X-rays, reported in Hounsfield units. A fibroid typically sits near normal myometrium in density, often in the range of soft tissue at roughly 40 to 60 Hounsfield units, so it does not stand out on a plain scan. What CT shows well is the silhouette of the uterus and the displacement of nearby organs. Large fibroids also often contain coarse calcifications, which appear bright and are easy to spot. The test also requires iodinated contrast and delivers ionizing radiation.

MRI aligns hydrogen protons in a strong magnetic field and reads the radio signal as it relaxes. Fibroids have a distinctive signature on T2-weighted images: well-circumscribed, low-signal whorls against higher-signal myometrium. That contrast, combined with multiplanar reformatting, lets MRI count, size, and locate every fibroid, including small ones. No ionizing radiation is involved.

The mechanism matters because it predicts failure modes. Ultrasound struggles when the uterus is large or the bowel sits in the way. CT struggles when a fibroid matches the density of surrounding muscle. MRI struggles mainly with cost, scan time, and patient tolerance.

Detection thresholds: what the numbers show

The published accuracy figures vary with study design, reference standard, and fibroid size, but the ranking is consistent. A 2016 systematic review of imaging for fibroids found that ultrasound and MRI both perform well, with MRI generally more sensitive and more reproducible for mapping. The review is a useful starting point because it compares the modalities head to head rather than in isolation.

Small fibroids set the practical floor. Transvaginal ultrasound can resolve lesions on the order of a few millimeters under good conditions, but detection falls off for lesions under about 5 millimeters, and confidence drops further when the uterus is enlarged or the fibroid is isoechoic, meaning it reflects sound much like normal muscle. CT is generally reported to detect fibroids above roughly 1 to 2 centimeters reliably; smaller lesions blend into the myometrium and are missed. MRI detects lesions at similar or smaller sizes and, critically, distinguishes them from adenomyosis and other mimics.

Size also determines what CT can say. A fibroid that distorts the uterine contour is easy to see. A 1-centimeter intramural lesion changes nothing about the outline, so CT has no cue. This is the core reason CT is not a screening test for fibroids.

One counterintuitive detail: MRI can overcall small low-signal foci that turn out to be normal junctional zone or small adenomyotic islands. Even the best test has false positives, which is why imaging is interpreted alongside symptoms and, where relevant, hysteroscopy.

Comparison table: CT vs. ultrasound vs. MRI

The table compresses a simple idea. Ultrasound answers whether a fibroid is likely present. MRI answers exactly where every fibroid sits and what else might mimic one. CT answers neither question well but is often already done for another reason.

Timeline: from symptom to image

The imaging pathway follows a predictable sequence, and knowing it helps patients understand why one test follows another.

The key point in the timeline is the fourth row. CT is usually not ordered to look for fibroids. It is ordered for abdominal pain, kidney stones, appendicitis, or staging of another condition. A fibroid is then described as an incidental finding. That framing changes how much detail the radiologist provides and how much you should trust the report for surgical planning.

Edge cases and mimics that change the answer

Several conditions look like fibroids on at least one modality, and the differences matter clinically.

Adenomyosis is endometrial tissue within the myometrium. On ultrasound it produces a thickened, asymmetric junctional zone; on MRI it shows ill-defined low signal on T2 that does not respect a capsule. A fibroid is well circumscribed. Confusing the two can lead to the wrong procedure, because adenomyosis responds differently to treatment than a discrete fibroid.

Submucosal fibroids are the ones most likely to cause heavy bleeding and fertility problems. They sit just under the endometrial lining, and their position is exactly what ultrasound may underreport and what MRI maps best. A fibroid described as intramural on ultrasound may prove submucosal on MRI.

Subserosal and pedunculated fibroids can mimic an ovarian mass. A pedunculated fibroid on a stalk may be mistaken for a solid ovarian tumor on CT, where density alone cannot separate them. Ultrasound and MRI, which show the stalk and the connection to the uterus, resolve this more often.

Leiomyosarcoma is a rare malignant tumor of the uterine muscle. It can look like a degenerating fibroid on all three tests. No imaging modality reliably distinguishes the two before surgery, which is a genuine limitation rather than a gap in technique. Rapid growth and certain MRI features raise suspicion but do not settle the diagnosis.

Red-flag warnings that should prompt urgent evaluation rather than routine imaging follow-up:

Postmenopausal bleeding with a new pelvic mass Rapidly enlarging uterine mass on serial imaging Severe pelvic pain with fever, suggesting degeneration or infection A mass that appears to arise from the ovary rather than the uterus New urinary or bowel obstruction symptoms

These bullets are not a diagnosis. They are reasons to seek care promptly.

Misconceptions and a professional caveat

The most common misconception is that a normal CT rules out fibroids. It does not. Because CT detection depends on size and contour change, a small or intramural fibroid can be entirely invisible on a scan read as normal. A patient with heavy bleeding and a normal CT still needs pelvic ultrasound.

A second misconception is that MRI is always better in every situation. MRI is more accurate for mapping, but it is slower, more expensive, less available in some settings, and poorly tolerated by patients with claustrophobia or certain implanted devices. The American College of Radiology appropriateness criteria place ultrasound as the initial test for pelvic pain and abnormal bleeding, with MRI reserved for problem solving. That ordering reflects real-world constraints, not just accuracy.

A third misconception confuses the number of fibroids with their clinical importance. A uterus with many small intramural fibroids may cause no symptoms, while one submucosal fibroid can cause severe bleeding. Imaging count matters less than location and size relative to the cavity.

The professional caveat worth stating plainly: the radiologist's report is a description, not a treatment plan. A CT report that mentions a 3-centimeter fibroid tells you the lesion exists and roughly how big it is. It does not tell you whether that fibroid explains the bleeding, whether it needs treatment, or how it should be removed. Those judgments require the full clinical picture and often a second imaging test.

Practical actions after imaging

What you do next depends on which test produced the finding and what question remains open.

If a CT incidentally found a fibroid and you have no symptoms, the usual step is no immediate action beyond routine follow-up. Many fibroids are found this way and never require treatment.

If you have symptoms such as heavy bleeding, pelvic pressure, or urinary frequency, ask for a transvaginal ultrasound if you have not had one. It is the appropriate next test and is widely available.

If ultrasound is ambiguous, if adenomyosis is suspected, or if surgery or uterine artery embolization is being planned, ask whether MRI would change the plan. MRI is justified when the location and number of fibroids determine the procedure.

If a CT report describes a mass that may be ovarian rather than uterine, ask for ultrasound or MRI to clarify the origin before any intervention.

If you have a known fibroid and new red-flag symptoms, seek care promptly rather than waiting for the next scheduled scan.

Practical thresholds are rough rather than absolute. A fibroid below about 1 to 2 centimeters is often missed on CT. A submucosal fibroid of any size matters more for bleeding than a larger intramural one. A uterus enlarged beyond about 12 to 14 weeks' gestational size is harder to assess completely on transabdominal ultrasound and may warrant transvaginal or MRI evaluation. Exact cutoffs vary by patient and operator, so treat them as planning guides rather than rules.

Limitations of the evidence and the tests

Three limits deserve explicit statement. First, most accuracy studies use surgery or pathology as the reference standard and enroll patients already referred for surgery, which can inflate apparent accuracy relative to a general screening population. Second, operator skill affects ultrasound more than MRI or CT, so single-center results may not transfer. Third, no modality reliably separates a fibroid from leiomyosarcoma before surgery, and no imaging test replaces clinical judgment about symptoms.

The tests also differ in what they can conclude. CT can conclude that a large mass distorts the uterus and may contain calcification. It cannot conclude that a small fibroid is absent. Ultrasound can conclude that a fibroid is likely present and give a size and rough location. It may not resolve exact cavity involvement. MRI can conclude with high confidence where each fibroid sits and whether adenomyosis coexists, within the limits of resolution and reader experience.

Returning to the original question: a CT scan can detect fibroids, especially large ones with calcification or contour change, but it is the weakest of the three tests for this purpose. Ultrasound is the right first test, and MRI is the right test when precision matters. The best test is the one matched to the question being asked, and the question is usually not whether a fibroid exists but whether it explains the symptoms and how it should be managed.

Citations: American College of Radiology Appropriateness Criteria for abnormal uterine bleeding and pelvic pain; a 2016 systematic review of imaging for uterine fibroids in a major radiology journal.